HealthCare Institute of New Jersey Issues Statement on Inflation Reduction Act’s New List of Medicines Subject to Price Controls
Trenton, August 15, 2024 ― The HealthCare Institute of New Jersey released the following statement concerning the Administration’s announcement of the next selected prescription medicines